A phase I clinical trial of AUTO-5
Latest Information Update: 12 Aug 2021
At a glance
- Drugs AUTO 5 (Primary)
- Indications T-cell lymphoma
- Focus Adverse reactions
- 05 Aug 2021 According to an Autolus Therapeutics media release, the company expects to initiate this trial in H1 2022.
- 10 Mar 2021 New trial record
- 04 Mar 2021 According to an Autolus Therapeutics media release, the company expects tp initiate this trial in H2 2021.